Can the new diabetes and weight loss drugs affect reproductive health?

Reproductive Health

A: Potentially, yes! Semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) may reduce birth control effectiveness and may increase risk of birth defects if taken during pregnancy. The new GLP-1 receptor agonist drugs have been a breakthrough in treating obesity and Type 2 diabetes. They significantly improve blood glucose levels and lower body weight. Read more…